The project:
CD8+ T cells are crucial players of immunity due to their paramount role in killing malignant and virally infected cells. This is why novel immunotherapy treatments use CD8+ T cells to eradicate cancer. In one of these treatments, the T cells are genetically modified to express artificial receptors that target specific proteins on cancer cells. This CAR (Chimeric Antigen Receptor) T cell therapy uses patients’ T cells to recognise and fight cancer and achieves up to 90% clinical responses against some blood cancers. However, CAR-T cells usually die early after administration, and their persistence depends on tumour type and production method. CAR-T cell therapy also shows very low efficacy against solid tumours due to low CAR-T cell infiltration within the tumour and the inhospitable tumour microenvironment. Long-lasting CAR-T cells that can infiltrate tumours better and persist for longer periods are crucial for successful therapy and prevention of disease relapse.
This project will investigate how to produce fitter CAR-T cells that can persist for longer and infiltrate solid tumours better. To do that we will focus on determining the role of low oxygenation (hypoxia) in T cell responses. We want to uncover how and why hypoxia can have both beneficial and detrimental effects and use the gained knowledge to improve CAR-T cell persistence in solid tumours.
We are looking for:
The successful candidate can grow in a lively and interactive working atmosphere within a well-connected network of PhD students and scientists
We offer:
Information can be obtained from Iosifina Foskolou, i.foskolou@sanquin.nl
Does this vacancy trigger you, do you recognize yourself in this profile? Please send us via the application button your motivation letterexplaining why this specific position is interesting for you, how your skillset would fit this research), together with your curriculum vitae,both in English.
Please send your application before the 1st of July 2023. After pre-selection of applications, we follow a two-step procedure, i.e.,
A pre-employment screening will be part of the onboarding procedure.
This application process is managed by the employer (Sanquin Blood Supply Foundation (Sanquin)). Please contact the employer for questions regarding your application.
Please contact the employer for questions regarding your application.
Tip: save this job as favorite in your AcademicTransfer account. This gives you an immediate overview and makes it easy to find the job later on. No account yet? Create it now and take advantage of other useful functionalities too!
Does this vacancy trigger you, do you recognize yourself in this profile? Please send us via the application button your motivation letterexplaining why this specific position is interesting for you, how your skillset would fit this research), together with your curriculum vitae,both in English.
Please send your application before the 1st of July 2023. After pre-selection of applications, we follow a two-step procedure, i.e.,
A pre-employment screening will be part of the onboarding procedure.
Does this vacancy trigger you, do you recognize yourself in this profile? Please send us via the application button your motivation letterexplaining why this specific position is interesting for you, how your skillset would fit this research), together with your curriculum vitae,both in English.
Please send your application before the 1st of July 2023. After pre-selection of applications, we follow a two-step procedure, i.e.,
A pre-employment screening will be part of the onboarding procedure.
Make sure to apply no later than 18 Jun 2023 23:58 (Europe/Amsterdam).
We like to make it easy for you, sign in for these and other useful features: